Skip to content

D&A at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$37M-5.1%
Opko Health logo
Opko HealthOPK
$18.97M-4.5%
Labcorp Holdings logo
Labcorp HoldingsLH
$75.6M+8.6%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$67.15M-44.2%
Veracyte logo
VeracyteVCYT
$5.43M+1.3%
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$832.61M-51.4%
Enterprise value$3.8B-20.1%
P/S0.3×-0.3×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's D&A?
QuidelOrtho Corporation (QDEL) reported D&A of $112.9M in Q1 2026.
How has QuidelOrtho Corporation's D&A changed year-over-year?
QuidelOrtho Corporation's D&A increased by 5.4% year-over-year, from $107.1M to $112.9M.
What is the long-term trend for QuidelOrtho Corporation's D&A?
Over 4 years (2021 to 2025), QuidelOrtho Corporation's D&A has grown at a 100.4% compound annual growth rate (CAGR), from $27.4M to $442M.
What does D&A mean?
Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.